346 related articles for article (PubMed ID: 24721588)
1. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
McCannel TA; McCannel CA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
[TBL] [Abstract][Full Text] [Related]
2. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
3. Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma.
Beykin G; Pe'er J; Hemo Y; Frenkel S; Chowers I
Br J Ophthalmol; 2013 Dec; 97(12):1534-7. PubMed ID: 24064939
[TBL] [Abstract][Full Text] [Related]
4. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
Retina; 2008; 28(7):987-95. PubMed ID: 18698302
[TBL] [Abstract][Full Text] [Related]
5. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
Douglas MJ; Scott IU; Flynn HW
Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma.
Oliver SC; Leu MY; DeMarco JJ; Chow PE; Lee SP; McCannel TA
Arch Ophthalmol; 2010 Jul; 128(7):888-93. PubMed ID: 20625051
[TBL] [Abstract][Full Text] [Related]
7. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
8. Early macular morphological changes following plaque radiotherapy for uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA
Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032
[TBL] [Abstract][Full Text] [Related]
9. The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series.
Ahuja Y; Kapoor KG; Thomson RM; Furutani KM; Shultz RW; Stafford SL; Dev S; Abu-Yaghi NE; Reynolds D; Pulido JS
Eye (Lond); 2012 Nov; 26(11):1487-9. PubMed ID: 22935669
[TBL] [Abstract][Full Text] [Related]
10. Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
Horgan N; Shields CL; Mashayekhi A; Salazar PF; Materin MA; O'Regan M; Shields JA
Ophthalmology; 2009 Jul; 116(7):1383-90. PubMed ID: 19481812
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of retinal detachment due to macular hole in myopic eyes treated by temporary silicone oil tamponade and laser photocoagulation.
Wolfensberger TJ; Gonvers M
Ophthalmology; 1999 Sep; 106(9):1786-91. PubMed ID: 10485551
[TBL] [Abstract][Full Text] [Related]
12. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
[TBL] [Abstract][Full Text] [Related]
13. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
14. Early subclinical macular edema in eyes with uveal melanoma: association with future cystoid macular edema.
Mashayekhi A; Schönbach E; Shields CL; Shields JA
Ophthalmology; 2015 May; 122(5):1023-9. PubMed ID: 25687025
[TBL] [Abstract][Full Text] [Related]
15. Plaque brachytherapy for uveal melanoma: a vision prognostication model.
Khan N; Khan MK; Bena J; Macklis R; Singh AD
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e285-90. PubMed ID: 22658514
[TBL] [Abstract][Full Text] [Related]
16. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
17. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma.
McCannel TA; Chang MY; Burgess BL
Ophthalmology; 2012 Mar; 119(3):606-10. PubMed ID: 22226884
[TBL] [Abstract][Full Text] [Related]
18. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
19. [Results of Iodine-125 radiotherapy in the treatment of uveal melanoma].
Caminal Mitjana JM; Quintana Casany M; Pera Fábregas J; Cinos Cope C; Guedea F
Arch Soc Esp Oftalmol; 2002 Jan; 77(1):29-38. PubMed ID: 11813118
[TBL] [Abstract][Full Text] [Related]
20. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
van Ginderdeuren R; van Limbergen E; Spileers W
Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]